§ Mr. Meacherasked the Chancellor of the Exchequer what evidence he has regarding the prevalence of transfer pricing by international companies; and, in view of the Monopolies Commission's 337W revelations regarding the pricing structures of Roche Products, what plans he has to survey the comparable activities of other similar companies.